Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Somaxon Pharmaceuticals Inc. v. Par Pharmaceutical Inc. et al
Case Number:
1:11-cv-00476
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 18, 2012
Somaxon Settles IP Rows With Mylan, Par Over Insomnia Drug
Somaxon Pharmaceutical Inc. said Tuesday it had settled patent infringement suits against generic drugmakers Mylan Inc. and Par Pharmaceutical Cos. Inc., striking deals that will keep generic versions of Somaxon's insomnia treatment drug from hitting the U.S. market until 2020.
-
May 27, 2011
Somaxon Slaps Par With 2nd Suit Over Generic Silenor
Somaxon Pharmaceuticals Inc. hit Par Pharmaceutical Cos. Inc. with a patent infringement suit in Delaware on Thursday, seeking to prevent the release of the generic drug maker's version of Somaxon's prescription insomnia medication Silenor.